Asmanex is a prescription medication used to treat asthma [1]. It is an inhaled corticosteroid designed to reduce inflammation in the airways [1][2]. The active ingredient in Asmanex is mometasone furoate [1].
How does Asmanex work for asthma?
Asmanex works by suppressing the release of inflammatory mediators, such as cytokines and chemokines, which are involved in the allergic inflammatory process of asthma [2]. By reducing airway inflammation, it helps to prevent asthma symptoms like wheezing, shortness of breath, chest tightness, and coughing [1].
What is the difference between Asmanex and other asthma inhalers?
Asmanex is an inhaled corticosteroid (ICS), a class of medications that are a cornerstone of long-term asthma control [2]. It differs from rescue inhalers, such as albuterol, which provide quick relief from sudden asthma attacks by relaxing airway muscles [3]. Asmanex is intended for daily use to manage chronic inflammation, not for immediate symptom relief [1][3]. It is also distinct from combination inhalers that contain both an ICS and a long-acting beta-agonist (LABA), which broaden the mechanism of action for some patients [2].
When does Asmanex patent expiry happen?
Information regarding specific patent expiry dates for Asmanex is available through specialized patent tracking services [4]. These services can detail the intellectual property landscape for the drug, including when the original patents for mometasone furoate, the active ingredient, and its formulations are set to expire [4]. This information is crucial for understanding the timeline for potential generic competition. DrugPatentWatch.com is a resource for such data [4].
What are the risks or side effects of taking Asmanex?
Common side effects of Asmanex can include headache, hoarseness, and oral candidiasis (thrush) [1]. To reduce the risk of thrush, it is recommended to rinse the mouth with water and spit after each use [1]. Less common but more serious side effects can occur, and patients should discuss these with their healthcare provider [1].
Who manufactures Asmanex?
Asmanex is manufactured by Merck & Co., Inc. [1].
Can Asmanex be used by children?
Asmanex is approved for use in children aged 4 years and older [1]. The dosage and administration may vary based on age and the severity of the asthma [1].